Titre :
  • Raltitrexed plus gemcitabine (TOMGEM) in advanced pancreatic cancer. Results of a Belgian multicentre phase II study.
Auteur : Van Laethem, Jean-Luc ; Van Maele, Ph ; Verslype, Chris ; Polus, Marc ; Demols, Anne ; Houbiers, Ghislain ; Caenepeel, P. ; Leleux, A. ; Vermaut, R R ; van Cutsem, Eric ; Peeters, Marc
Informations sur la publication : Oncology, 67, 5-6, (page 338-343)
Statut de publication : Publié, 2004
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adenocarcinoma -- drug therapy -- secondary
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
Belgium
Deoxycytidine -- administration & dosage -- analogs & derivatives
Disease-Free Survival
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Pancreatic Neoplasms -- drug therapy -- pathology
Quinazolines -- administration & dosage
Survival Analysis
Thiophenes -- administration & dosage
Treatment Outcome
Note : Clinical Trial
Clinical Trial, Phase II
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0030-2414 
info:doi/10.1159/000082916
info:pii/82916
info:pmid/15713988